Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatment
Patients with GLOBE-defined low-risk and LSM > 11 kPa had a poor prognosis, and antifibrotic therapy may slow the progression of liver stiffness in these patients.
Authors
- Boling Wang
- Lina Cui (ORCID: https://orcid.org/0000-0002-8149-5206)
- Guanya Guo (ORCID: https://orcid.org/0000-0001-5115-1632)
- Juan Deng (ORCID: https://orcid.org/0000-0002-1811-4183)
- Yulong Shang (ORCID: https://orcid.org/0000-0002-8576-3175)
- Yinan Hu (ORCID: https://orcid.org/0000-0002-9304-519X)
- Ying Han (ORCID: https://orcid.org/0000-0003-3046-9507)
- Dawei Ding (ORCID: https://orcid.org/0000-0003-0201-5081)
- Linhua Zheng
- Xiufang Wang (ORCID: https://orcid.org/0000-0002-4223-8004)
- Ruiqing Sun
- Gui Jia
Institutions
- National Clinical Research Center for Digestive Diseases (CN)
- Xijing Hospital (CN)
Publication Details
- Journal
- Hepatology International
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1007/s12072-024-10743-w
- Citations
- 4
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 1.48
Funders
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province